JEFFERY ARMSTRONG: Open Payments
NPI 1972597136 · WASHINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 43 payments from 15 companies in 2025. Trend: 2023 $832 · 2024 $1,290 · 2025 $965
Food & beverage: $782Education: $183
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $250 |
| ABBVIE INC. | 10 | $186 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $107 |
| UCB, Inc. | 3 | $81 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| Amgen Inc. | 3 | $44 |
| Lilly USA, LLC | 2 | $34 |
| Galderma Laboratories, L.P. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
Products named: TREMFYA, Cabtreo, SKYRIZI, RINVOQ, Bimzelx, DUPIXENT, OTEZLA, Rhapsido.
Industry payments across MO — which companies pay providers there.
